• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Arthritis Research & Therapy

    Arthritis Research & Therapy

    JournalISSN 1478-6354eISSN 1478-6362中科院 医学 2区

    年发文量

    研究主题

    论文(8258)

    排序
    1NewVery Early Pulmonary Function Decline in Systemic Sclerosis: Longitudinal Evidence from the STRIKE and EUSTAR VEDOSS Cohorts
    Vishal Kakkar,Stefano Di Donato, Nicola Ortalli,Florenzo Iannone,Gábor Kumánovics,Radim Bečvář,Vanessa Smith,Andra Balanescu,Ulf Mueller-Ladner,Roberta Foti,Emmanuel Chatelus,Jelena Colic,

    Mean forced vital capacity (FVC) at interstitial lung disease (ILD) diagnosis in EUSTAR is approximately 87

    2026
    引用
    AI阅读
    加入学术空间
    2NewObesity and Fibromyalgia Are Associated with a Difficult-to-manage Psoriatic Arthritis Phenotype and Adverse Long-Term Outcomes
    Antonios Bertsias,Irini Flouri,Evgenia Emmanouilidou,Argyro Repa,Eleni Kalogiannaki,Sofia Pitsigavdaki,Nestor Avgoustidis,Georgios Bertsias,Prodromos Sidiropoulos

    The concept of difficult-to-manage (D2M) psoriatic arthritis (PsA) has been recently proposed. Herein, we report on the prevalence, predictors and outcomes of D2M PsA. This is a prospective single-center cohort study of PsA patients initiating b/tsDMARDs from 01/01/2009 until 01/01/2025. The EULAR proposed definition for D2M PsA was applied. Baseline parameters were assessed as predictors of D2M development using multiple logistic regression models. Long-term outcomes were compared between D2M and non-D2M patients by evaluating functional progression and adverse event rates. During a median follow-up time of 3.4 years, 46/350 patients (13.1

    2026
    引用
    AI阅读
    加入学术空间
    3NewIntegrating Network Toxicology, Interpretable Machine Learning, and Molecular Docking to Unravel Key Molecular Networks in Diethyl Phthalate-Related Rheumatoid Arthritis
    Qingchen Jiang,Xiangyuan Wu,Wen Zhang,Ming Li, Lu Shao, Junmiao Xie,Juan Yang,Teng Chen,Biao Wang,Yanjiong Chen,Li Xue

    Diethyl phthalate (DEP) is widely used in everyday consumer products and has been associated with an increased risk of rheumatoid arthritis (RA), but its potential mechanisms remain unclear. This study elucidated the potential computational links between DEP and the molecular networks implicated in RA pathogenesis. Employing a network toxicology framework, we systematically delineated DEP-related molecular networks and screened key RA targets by integrating target prediction, RA transcriptomic data mining, interpretable machine learning, and molecular docking. Following batch correction, we conducted differential expression analysis and weighted gene co-expression network analysis (WGCNA), followed by functional enrichment of the intersecting targets. Core genes were prioritized via multiple machine-learning algorithms interpreted using SHapley Additive exPlanations (SHAP). Finally, molecular docking and molecular dynamics (MD) simulations were performed to computationally assess structural binding stability. A total of 69 targets overlapping between DEP and RA were identified. Among the constructed models, the LASSO-RF sequential framework achieved optimal discrimination, with an apparent AUC of 0.9998 (95

    2026
    引用
    AI阅读
    加入学术空间
    4NewImmune Checkpoint Inhibitors in Patients with Rheumatoid Arthritis: a Matched Cohort Study of Immune-Related Adverse Events and Survival
    Yu-Seon Jung,Se Rim Choi, Yae-Jin Cha, Yongbum Kim,Soo-Kyung Cho,Sun-Young Jung,Yoon-Kyoung Sung

    Patients with pre-existing rheumatoid arthritis (RA) are increasingly treated with immune checkpoint inhibitors (ICIs), but RA-specific evidence on immune-related adverse events (irAEs) and survival remains limited because autoimmune disease patients were largely excluded from pivotal trials. We aimed to evaluate the risk of irAEs and overall survival (OS) in patients with pre-existing RA initiating ICIs compared with matched non-RA controls. We conducted a nationwide matched cohort study using the National Health Information Database (NHID) of the National Health Insurance Service (NHIS). Patients with RA initiating ICIs (2018–2022) were matched (1:4) to non-RA controls by age, sex, Charlson Comorbidity Index, index year, and cancer type. irAEs were defined as events requiring systemic corticosteroids with ICI interruption or discontinuation. Incidence rate ratios (IRRs) of irAEs and hazard ratios (HRs) for OS were estimated using Cox models, with cancer-specific subgroup analyses. Among 17,971 ICI-treated cancer patients, 759 with RA and 2647 matched patients without RA were included. The incidence of irAEs was comparable between groups (IRR 0.92, 95

    2026
    引用
    AI阅读
    加入学术空间
    5NewConfirmation of Anti-Terf1 Autoantibodies in Systemic Sclerosis and Fibrotic Lung Disease Using a Novel Particle-Based Immunoassay
    Kristen R. Mathias,Michael Mahler,Chelsea Bentow,Mary Ann Aure, Chatuthanai Savigamin,Ami A. Shah,Livia Casciola-Rosen,Marvin J. Fritzler,May Y. Choi,Brittany L. Adler

    Anti-TERF1 autoantibodies were previously identified in systemic sclerosis (SSc) sera and were associated with severe lung involvement, adding to earlier evidence that telomere dysregulation may contribute to disease pathogenesis. Nevertheless, the report of anti-TERF1 autoantibodies in SSc has not been confirmed in an independent cohort. We sought to confirm the presence of anti-TERF1 autoantibodies in patients with SSc using a novel particle-based multi-analyte technology (PMAT) and to characterize antibody specificity by epitope mapping. A comparability study assessing agreement between a research-use only (RUO) enzyme-linked immunosorbent assay (ELISA) and a RUO PMAT assay developed for detection of anti-TERF1 autoantibodies was performed on sera from 42 individuals, including 32 with SSc and 5 healthy controls. Anti-TERF1 autoantibodies were subsequently measured in a cross-sectional cohort of 381 patients, including 133 with SSc, 28 with idiopathic pulmonary fibrosis/interstitial pneumonia with autoimmune features (IPF/IPAF), 198 with other autoimmune or infectious diseases, and 22 healthy controls. Exploratory epitope mapping of the TERF1 autoantigen was performed using pooled sera to probe a custom peptide microarray. A strong correlation was observed between ELISA and PMAT assays (Spearman rho = 0.805 [95

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 8258 篇论文

    高被引作者

    作者引用发文
    Josef Smolen774994
    Gerd-Rüdiger Burmester513464
    Paul Peter Tak463381
    Johanne Martel-Pelletier436064
    Jean-Pierre Pelletier434462
    Steffen Gay427464
    Cem Gabay416330
    Thomas Huizinga400083
    Judith Hoyland377816
    Flavia Cicuttini346752

    高产作者

    作者引用发文
    Josef Smolen774994
    Thomas Huizinga400083
    Paul Peter Tak463381
    Johanne Martel-Pelletier436064
    Gerd-Rüdiger Burmester513464
    Steffen Gay427464
    Jean-Pierre Pelletier434462
    Wim B. van den Berg327561
    Lars Klareskog340555
    Nicola Dalbeth235455

    相关期刊

    Arthritis and rheumatism
    Clinical and experimental rheumatology
    Rheumatology
    Joint Bone Spine
    Current Rheumatology Reports
    International Journal Of Rheumatic Diseases
    Arthritis & Rheumatology
    Annals of the Rheumatic Diseases
    Seminars in Arthritis and Rheumatism
    Nature Reviews Rheumatology